These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16172223)

  • 1. Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Sayed-Tabatabaei FA; Coebergh JW; Hofman A; Njajou O; Stricker B; van Duijn C
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2143-6. PubMed ID: 16172223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk.
    González-Zuloeta Ladd AM; Arias Vásquez A; Siemes C; Yazdanpanah M; Coebergh JW; Hofman A; Stricker BH; van Duijn CM
    Breast Cancer Res Treat; 2007 Mar; 101(3):299-304. PubMed ID: 16823505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan.
    Sugimoto M; Furuta T; Shirai N; Ikuma M; Sugimura H; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1929-34. PubMed ID: 17035401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S; Spina L; Virgilio T; Folcioni A; Borsi G; de Franchis R; Cugno M; Vecchi M
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran.
    Namazi S; Daneshian A; Mohammadianpanah M; Jafari P; Ardeshir-Rouhani-Fard S; Nasirabadi S
    Gene; 2013 Dec; 532(1):125-31. PubMed ID: 24055489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort.
    Haiman CA; Henderson SO; Bretsky P; Kolonel LN; Henderson BE
    Cancer Res; 2003 Oct; 63(20):6984-7. PubMed ID: 14583500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women.
    Freitas-Silva M; Pereira D; Coelho C; Bicho M; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2004 Nov; 155(1):42-6. PubMed ID: 15527901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion/deletion polymorphism of angiotensin-converting enzyme gene--risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina).
    Terzić R; Letonja M; Terzić I; Sehić A; Merić M; Teran N
    Coll Antropol; 2003 Dec; 27(2):537-40. PubMed ID: 14746140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study.
    Sayed-Tabatabaei FA; Schut AF; Arias Vásquez A; Bertoli-Avella AM; Hofman A; Witteman JC; van Duijn CM
    J Med Genet; 2005 Jan; 42(1):26-30. PubMed ID: 15635071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer.
    Yaren A; Oztop I; Turgut S; Turgut G; Degirmencioglu S; Demirpence M
    Exp Biol Med (Maywood); 2008 Jan; 233(1):32-7. PubMed ID: 18156303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
    Ravn LS; Benn M; Nordestgaard BG; Sethi AA; Agerholm-Larsen B; Jensen GB; Tybjaerg-Hansen A
    Pharmacogenet Genomics; 2008 Jun; 18(6):525-33. PubMed ID: 18496132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of angiotensin I converting enzyme insertion/deletion polymorphism with breast cancer: a meta-analysis.
    Sun M; Liu C; Wei F; Zhong J; Sun Y
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):611-6. PubMed ID: 21546404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension.
    Boström KB; Hedner J; Melander O; Grote L; Gullberg B; Råstam L; Groop L; Lindblad U
    J Hypertens; 2007 Apr; 25(4):779-83. PubMed ID: 17351369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.